Skip to main content

Table 2 Univariate analysis (group 2) for use of temporary pacing according to demographic, and preoperative variables a

From: Predictors of temporary epicardial pacing wires use after valve surgery

Variable Temporary cardiac pacing
  No Yes p-value
Age (year)    0.013
  < 40 13 (81.3) 3 (18.8)  
  40–59 84 (84.8) 15 (15.20)  
  ≥ 60 78 (67.8) 37 (32.2)  
Sex    
  Female 79 (72.5) 30 (27.5) 0.223
  Male 96 (79.3) 25 (20.7)  
Renal failure (creatinine > 1.5 mg/dl)    0.991
  No 159 (76.1) 50 (23.9)  
  Yes 16 (76.2) 5 (23.8)  
Diabetes mellitus    0.001
  No 119 (70.4) 50 (29.6)  
  Yes 56 (91.8) 5 (8.2)  
COPD    0.504
  No 161 (76.7) 49 (23.3)  
  Yes 14 (70.0) 6 (30.0)  
History of arrhythmia    0.818
  No 144 (75.8) 46 (24.2)  
  Yes 31 (77.5) 9 (22.5)  
NYHA class    0.000
  I-II 136 (90.1) 15 (9.9)  
  III-IV 39 (49.4) 40 (50.6)  
Left Ventricle ejection fraction (%)    0.001
  > 35 114 (83.8) 22 (16.2)  
  ≤ 35 61 (64.9) 33 (35.1)  
PAP (mmHg)    0.000
  < 50 171 (85.1) 30 (14.9)  
  ≥ 50 4 (13.8) 25 (86.2)  
Left atrium diameter (mm)    0.104
  < 5.2 155 (77.9) 44 (22.1)  
  ≥ 5.2 20 (64.5) 11 (35.5)  
Beta blockers    0.002
  No 119 (70.8) 49 (29.2)  
  Yes 56 (90.3) 6 (9.70)  
Digoxin    0.440
  No 159 (76.8) 48 (23.2)  
  Yes 16 (69.6) 7 (30.4)  
Amiodarone    0.011
  No 167 (78.0) 47 (22.0)  
  Yes 8 (50.0) 8 (50.0)  
  1. aData are given as no. (%).
  2. COPD = chronic obstructive pulmonary disease; NYHA = New York Heart Association; PAP =pulmonary artery pressure.